4.5 (612) · $ 7.00 · In stock
The FDA has approved the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making.
Tom Lachaise on LinkedIn: STAT
Benjamin Hulot posted on LinkedIn
Tom Lachaise on LinkedIn: STAT
Benjamin Hulot on LinkedIn
FDA approves the first-ever RSV vaccine
Benjamin Hulot on LinkedIn: FDA approves first-ever RSV vaccine, as GSK eyes 'Shingrix-like' product
Benjamin Hulot on LinkedIn: FDA approves first-ever RSV vaccine, as GSK eyes 'Shingrix-like' product
FDA approves the first-ever RSV vaccine
Benjamin Hulot posted on LinkedIn